"/> Invitrogen™ Peptide synthétique APRIL humain | B-LABO France

Invitrogen™ Peptide synthétique APRIL humain

Réf. : BL-RE-176322Réf. fabricant : 15206299 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
8741
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
O75888
Nom usuel
Human APRIL
Marque
Invitrogen

APRIL Synthetic Peptide, PEP-0067, from Invitrogen.

Members in the TNF superfamily regulate immune responses and induce apoptosis. A novel member in the TNF family was recently identified by several groups and designated APRIL (for A PRoliferation-Inducing Ligand), TALL2 (for TNF and ApoL-related Leukocyte-expressed Ligand 2), and TRDL 1a (for TNF related death ligand 1a) in human and mouse. Two receptors for APRIL were recently identified and designated TACI and BCMA. APRIL stimulates B and T cell proliferation, triggers humoral immune responses, activates NF-kB, and induces cell death. APRIL and its close relative of BlyS and their receptors BCMA and TACI are involved in diseases of autoimmunity and cancer.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176322
Réf. fabricant15206299
Gene ID (Entrez)8741
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionO75888
Nom usuelHuman APRIL
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)TNFSF13
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.